Micrus Endovascular (MEND) Tops Q1 Results By 9c
More News related to MEND
- Susquehanna Maintains a 'Positive' Rating on Micrus Endovascular (MEND); Long-Term Story Remains Intact
- Morning Movers 11/05: ROYL, RX, FSYS, KAI, SANM Higher; SMSI, CVS, MBRK, INOD, PL, ARO Lower
- Micrus Endovascular (MEND) Posts Q3 EPS of $0.22, Tops Street Views
- Micrus Endovascular Reports Fiscal Second Quarter Revenues of $21.5 Million and Diluted EPS of $0.22
- Micrus Endovascular to Present at the Canaccord Cardiovascular Conference
Micrus Endovascular (Nasdaq: MEND) reports Q1 EPS of $0.04, 9 cents better than the analyst estimate of ($0.05). Revenue for the quarter was $20.8 million, versus the consensus of $19.4 million.
Click Here To Try StreetInsider's LIVE NEWS FEED for FREE for a limited time! http://www.streetinsider.com/premium_content.php
Related Categories
EarningsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
